Risk of Gastric Injury with Enteric- versus Nonenteric-Coated Aspirin

Abstract

Spanish

French

OBJECTIVE:

To evaluate through clinical trials the risk of various aspirin preparations on the gastric mucosa.

DATA SOURCES:

Articles reporting clinical research were accessed through MEDLINE (1980–November 1998). Key search terms included enteric-coated aspirin, buffered aspirin, and gastrointestinal (GI) bleeding.

DATA SYNTHESIS:

Aspirin products are known to cause GI bleeding. Enteric-coated aspirin may provide an additional protective effect on gastric mucosa compared with buffered aspirin. An evaluation of studies comparing various aspirin preparations and the risk of gastric mucosal injury was conducted.

CONCLUSIONS:

For long-term use, enteric-coated aspirin may provide a safer alternative than buffered aspirin; however, further studies are necessary.

Keywords

buffered aspirin enteric-coated aspirin gastric ulcer

Get full access to this article

View all access options for this article.

References

Silagy

McNeil

Donnan

Tonkin

Worsam

Campion

. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 1993; 54: 84–9.

Fries

Ramey

Singh

Morfeld

Bloch

Raynauld

. A reevaluation of aspirin therapy in rheumatoid arthritis. Arch Intern Med 1993; 153: 2465–71.

Graham

Smith

. Aspirin and the stomach. Ann Intern Med 1986; 104: 390–8.

Lanza

Royer

Nelson

. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136–8.

Hawthorne

Mahida

Cole

Hawkey

. Aspirin-induced gastric mucosal damage: Prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991; 32: 77–83.

Petroski

. Endoscopic comparison of three aspirin preparations and placebo. Clin Ther 1993; 15: 314–20.

Weil

Colin-Jones

Langman

Lawson

Logan

Murphy

. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827–30.

Prichard

Kitchingman

Walt

Dancshmend

Hawkey

. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ 1989; 298: 493–6.

Lanza

Rack

Wagner

. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four × a day. Dig Dis Sci 1985; 30: 509–12.

10.

Hoftiezer

Burks

Silvoso

Ivey

. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; 2: 609–12.

11.

Kelly

Kaufman

Jurgelon

Sheehan

Koff

Shapiro

. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric coated or buffered product. Lancet 1996; 348: 1413–6.